tradingkey.logo

iSpecimen Inc

ISPC
0.330USD
-0.015-4.38%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
3.22MMarktkapitalisierung
VerlustKGV TTM

iSpecimen Inc

0.330
-0.015-4.38%

mehr Informationen über iSpecimen Inc Unternehmen

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

iSpecimen Inc Informationen

BörsenkürzelISPC
Name des UnternehmensiSpecimen Inc
IPO-datumJun 17, 2021
CEOField (Katharyn)
Anzahl der mitarbeiter24
WertpapierartOrdinary Share
GeschäftsjahresendeJun 17
Addresse8 Cabot Road
StadtWOBURN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl08101
Telefon17813016700
Websitehttps://www.ispecimen.com/
BörsenkürzelISPC
IPO-datumJun 17, 2021
CEOField (Katharyn)

Führungskräfte von iSpecimen Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Specimens – contracts with customers
95.82K
89.89%
Shipping and other
10.78K
10.11%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Specimens – contracts with customers
95.82K
89.89%
Shipping and other
10.78K
10.11%

Aktionärsstatistik

Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Andere
96.62%
Aktionäre
Aktionäre
Anteil
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
Andere
96.62%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
1.59%
Research Firm
0.86%
Investment Advisor
0.70%
Corporation
0.43%
Investment Advisor/Hedge Fund
0.43%
Individual Investor
0.26%
Andere
95.73%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
27
349.56K
3.58%
+223.90K
2025Q3
26
96.86K
1.75%
-11.14K
2025Q2
31
133.51K
3.29%
-45.19K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Renaissance Technologies LLC
153.46K
1.53%
+153.46K
--
Sep 30, 2025
Virtu Americas LLC
63.26K
0.63%
+63.26K
--
Sep 30, 2025
OBF Investments LLC
42.10K
0.42%
+1.00
+0.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
41.69K
0.42%
+26.88K
+181.52%
Sep 30, 2025
Scientech Research LLC
29.49K
0.29%
+29.49K
--
Sep 30, 2025
The Vanguard Group, Inc.
29.41K
0.29%
+28.17K
+2277.28%
Sep 30, 2025
Wolf (James G)
25.25K
0.25%
-14.29K
-36.14%
Jun 03, 2024
Jane Street Capital, L.L.C.
20.26K
0.2%
+20.26K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.83K
0.03%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Datum
Ex-Dividendentag
Art
Verhältnis
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
KeyAI